Jump to content
IndiaDivine.org

FDA reaches agreement with Burzynski

Rate this topic


Guest guest

Recommended Posts

Goode news? . . .

 

Ralph W. Moss, Ph.D. Weekly CancerDecisions.com

Newsletter #375 01/18/09

 

CANCER DECISIONS FREE WEEKLY NEWSLETTER

 

We are gratified and excited by the announcement this week that the Food

and Drug Administration (FDA) has reached an agreement with the

Burzynski Research Institute, Inc., for the design of a phase III trial

of antineoplaston therapy for the treatment of diffuse intrinsic

brainstem glioma, a rare but highly aggressive form of childhood brain

cancer.

 

To read this week's newsletter, please click or go to:

http://www.cancerdecisions.com/011809.html

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...